NorthWest Biotherapeutics Inc (NWBO)

[DocLee]

If it is now legal under U.K. law for an unproven medical product (DCVax-L) to be produced at Sawston and used in the UK, would it also be lawful for the same process by which DCVax-L is produced to be used to produce a dendritic cell vaccine for another malignancy? All that would be needed is for a biopsy specimen of, say, pancreatic tumour to be used instead of a specimen of Glioblstoma Multiforme.

Of course, if it were allowable in law, the recipient of the DCVax-Pancreatic would have to pay for it, but that is what is already being done with DCVax-L.